Question:
Match the following biochemical transformations with coenzymes involved
(i) α-Ketoglutarate to glutamic acid Tetrahydrofalate (ii) Uridine to thymidine. NADH (iii) Pyruvid acid to acetyl coenzyme A Thiamine pyrophosphate Pyridoxamine
Match the following biochemical transformations with coenzymes involved
| (i) α-Ketoglutarate to glutamic acid | Tetrahydrofalate |
| (ii) Uridine to thymidine. | NADH |
| (iii) Pyruvid acid to acetyl coenzyme A | Thiamine pyrophosphate |
| Pyridoxamine |
Updated On: Aug 11, 2024
- i-d, ii-a, iii-c
- i-a, ii-b, iii-d
- i-b, ii-a, iii-c
- i-d, ii-b, iii-c
Hide Solution
Verified By Collegedunia
The Correct Option is C
Solution and Explanation
The correct option is (C) : i-b, ii-a, iii-c
Was this answer helpful?
0
0
Top Questions on Enzymes
- Describe briefly, the charge relay system that operates in chymotrypsin enzyme.
The graph showing the concept of activation energy of enzyme is given below. Observe the graph and choose the correct option for M and N.
- Assertion (A): Restriction endonuclease recognises palindromic sequence in DNA and cuts them. Reason (R): Palindromic sequence has two unique recognition sites PstI and PvuI recognised by restriction endonuclease.
- Streptokinase produced by bacterium Streptococcus is used for:
- Which one of the following enzymes contains 'Heme' as the prosthetic group?
View More Questions
Questions Asked in GPAT exam
- Match the following:
(1) Schedule FF
(2) Schedule F3
(3) Schedule V
(4) Schedule Y
Descriptions:
(P) Standards of patent and proprietary medicines
(Q) Requirements and guidelines for clinical trials
(R) Standards for sterilized umbilical tapes
(S) Standards for Ophthalmic preparations- GPAT - 2025
- Drug therapy
- If the label or the container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist, it is:
- GPAT - 2025
- Drug therapy
- Manufacturing Specification for tooling has been standardized by?
- GPAT - 2025
- Pharmacy Profession & Introduction to Pharmaceuticals
- As per USP, the maximum concentration of benzalkonium chloride used as a preservative in parenteral formulations is
- GPAT - 2025
- Pharmaceutical Analysis
Match the following:
(P) Schedule H
(Q) Schedule G
(R) Schedule P
(S) Schedule F2
Descriptions:
(I) Life period of drugs
(II) Drugs used under RMP
(III) List of Prescription Drugs
(IV) Standards for surgical dressing
- GPAT - 2025
- Drug therapy
View More Questions